» Articles » PMID: 22969764

IL-2 Expression in Activated Human Memory FOXP3(+) Cells Critically Depends on the Cellular Levels of FOXP3 As Well As of Four Transcription Factors Of  T Cell Activation

Overview
Journal Front Immunol
Date 2012 Sep 13
PMID 22969764
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The human CD4(+)FOXP3(+) T cell population is heterogeneous and consists of various subpopulations which remain poorly defined. Anergy and suppression are two main functional characteristics of FOXP3(+)Treg cells. We used the anergic behavior of FOXP3(+)Treg cells for a better discrimination and characterization of such subpopulations. We compared IL-2-expressing with IL-2-non-expressing cells within the memory FOXP3(+) T cell population. In contrast to IL-2-non-expressing FOXP3(+) cells, IL-2-expressing FOXP3(+) cells exhibit intermediate characteristics of Treg and Th cells concerning the Treg cell markers CD25, GITR, and Helios. Besides lower levels of FOXP3, they also have higher levels of the transcription factors NFATc2, c-Fos, NF-κBp65, and c-Jun. An approach combining flow cytometric measurements with statistical interpretation for quantitative transcription factor analysis suggests that the physiological expression levels not only of FOXP3 but also of NFATc2, c-Jun, c-Fos, and NF-κBp65 are limiting for the decision whether IL-2 is expressed or not in activated peripheral human memory FOXP3(+) cells. These findings demonstrate that concomitant high levels of NFATc2, c-Jun, c-Fos, and NF-κBp65 lead in addition to potential IL-2 expression in those FOXP3(+) cells with low levels of FOXP3. We hypothesize that not only the level of FOXP3 expression but also the amounts of the four transcription factors studied represent determining factors for the anergic phenotype of FOXP3(+) Treg cells.

Citing Articles

"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity".

Lykhopiy V, Malviya V, Humblet-Baron S, Schlenner S Genes Immun. 2023; 24(5):248-262.

PMID: 37741949 PMC: 10575774. DOI: 10.1038/s41435-023-00221-y.


Automated clustering reveals CD4 T cell subset imbalances in rheumatoid arthritis.

Mulhearn B, Marshall L, Sutcliffe M, Hannes S, Fonseka C, Hussell T Front Immunol. 2023; 14:1094872.

PMID: 37215131 PMC: 10196473. DOI: 10.3389/fimmu.2023.1094872.


The Importance of the Transcription Factor Foxp3 in the Development of Primary Immunodeficiencies.

Mertowska P, Mertowski S, Podgajna M, Grywalska E J Clin Med. 2022; 11(4).

PMID: 35207219 PMC: 8874698. DOI: 10.3390/jcm11040947.


Global intron retention mediated gene regulation during CD4+ T cell activation.

Ni T, Yang W, Han M, Zhang Y, Shen T, Nie H Nucleic Acids Res. 2016; 44(14):6817-29.

PMID: 27369383 PMC: 5001615. DOI: 10.1093/nar/gkw591.


Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models.

Mendioroz M, Do C, Jiang X, Liu C, Darbary H, Lang C Genome Biol. 2015; 16:263.

PMID: 26607552 PMC: 4659173. DOI: 10.1186/s13059-015-0827-6.


References
1.
Miyara M, Sakaguchi S . Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol Cell Biol. 2011; 89(3):346-51. DOI: 10.1038/icb.2010.137. View

2.
Hori S, Nomura T, Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299(5609):1057-61. DOI: 10.1126/science.1079490. View

3.
Hentsch B, Mouzaki A, Pfeuffer I, Rungger D, Serfling E . The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity. Nucleic Acids Res. 1992; 20(11):2657-65. PMC: 336904. DOI: 10.1093/nar/20.11.2657. View

4.
Bianchini R, Bistoni O, Alunno A, Petrillo M, Ronchetti S, Sportoletti P . CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. Eur J Immunol. 2011; 41(8):2269-78. DOI: 10.1002/eji.201040943. View

5.
Gavin M, Rasmussen J, Fontenot J, Vasta V, Manganiello V, Beavo J . Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007; 445(7129):771-5. DOI: 10.1038/nature05543. View